Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery.

In vivo electroporation (EP) is gaining momentum for drug and gene delivery. In particular, DNA transfer by EP to muscle tissue can lead to highly efficient long-term gene expression. We characterized a vascular effect of in vivo EP and its consequences for drug and gene delivery. Pulses of 10-20,000 micros and 0.1-1.6 kV/cm were applied over hind- and forelimb of mice and perfusion was examined by dye injection. The role of a sympathetically mediated vasoconstrictory reflex was investigated by pretreatment with reserpine. Expression of a transferred gene (luciferase), permeabilization (determined using (51)Cr-EDTA), membrane resealing and effects on perfusion were compared to assess the significance of the vascular effects. Above the permeabilization threshold, a sympathetically mediated Raynaud-like phenomenon with perfusion delays of 1-2 min was observed. Resolution of this phase followed kinetics of membrane resealing. Above a second threshold, irreversible permeabilization led to long perfusion delays. These vascular reactions (1) affect kinetics of drug delivery, (2) predict efficient DNA transfer, which is optimal during short perfusion delays, and (3) might explain electrocardiographic ST segment depressions after defibrillation as being caused by vascular effects of EP of cardiac muscle.

[1]  Darius Moradpour,et al.  In vivo gene electroinjection and expression in rat liver , 1996, FEBS letters.

[2]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[3]  M. Rand,et al.  The Pharmacology of Rauwolfia Alkaloids , 1977 .

[4]  S. Takeshita,et al.  Increased expression of direct gene transfer into skeletal muscles observed after acute ischemic injury in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[5]  M. Jaroszeski,et al.  Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin , 1998, Cancer.

[6]  L. Chernomordik,et al.  Electroporation and electrophoretic DNA transfer into cells. The effect of DNA interaction with electropores. , 1992, Biophysical journal.

[7]  M. Rols,et al.  In vivo electrically mediated protein and gene transfer in murine melanoma , 1998, Nature Biotechnology.

[8]  M. Bureau,et al.  High-efficiency gene transfer into skeletal muscle mediated by electric pulses. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[9]  T Nakada,et al.  Successful treatment of metastatic skin lesions with electrochemotherapy. , 1998, The Journal of urology.

[10]  J. Gehl,et al.  Electroporation of muscle tissue in vivo. , 2000, Methods in molecular medicine.

[11]  R. Kronmal,et al.  Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic Investigators. , 1996, Circulation.

[12]  J. Gehl,et al.  Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. , 1999, Biochemical and biophysical research communications.

[13]  R. Lee,et al.  Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells. , 1999, Bioelectromagnetics.

[14]  Richard Heller,et al.  Electrochemotherapy, Electrogenetherapy, and Transdermal Drug Delivery , 2000 .

[15]  L. Salford,et al.  Studies of in vivo electropermeabilization by gamma camera measurements of (99m)Tc-DTPA. , 1999, Biochimica et biophysica acta.

[16]  D Miklavcic,et al.  Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[18]  M Cemazar,et al.  Tumour blood flow changes induced by application of electric pulses. , 1999, European journal of cancer.

[19]  Leslie Tung,et al.  Effects of Strong Electrical Shock on Cardiac Muscle Tissue a , 1994, Annals of the New York Academy of Sciences.

[20]  A. Benabid,et al.  Muscle transfection by electroporation with high-voltage and short-pulse currents provides high-level and long-lasting gene expression. , 2000, Human gene therapy.

[21]  L. Mir,et al.  Electrochemotherapy, a new antitumor treatment. First clinical phase I‐II trial , 1993, Cancer.

[22]  D Miklavcic,et al.  Tumor blood flow modifying effect of electrochemotherapy with bleomycin. , 1999, Anticancer research.

[23]  J. Isner,et al.  Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. , 1996, Circulation.

[24]  M. Bureau,et al.  Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. , 2000, Biochimica et biophysica acta.

[25]  S. Orlowski,et al.  Electrochemotherapy on liver tumours in rabbits. , 1998, British Journal of Cancer.

[26]  P Raskmark,et al.  In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. , 1999, Biochimica et biophysica acta.

[27]  H. Aihara,et al.  Gene transfer into muscle by electroporation in vivo , 1998, Nature Biotechnology.

[28]  J. Gehl,et al.  Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy , 2000, Melanoma research.

[29]  R. Lee,et al.  Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. , 1992, Proceedings of the National Academy of Sciences of the United States of America.